The death of a British journalist, whose family claims she died from complications after receiving the AstraZeneca COVID-19 vaccination, has prompted an investigation.
Lisa Shaw, a BBC broadcaster who died on Friday, was treated for blood clots days after her first jab, according to her family.
The claims are currently being investigated by a coroner.
According to the BBC, the vaccine is listed as one of the possible factors being investigated in the interim fact-of-death certificate.
Shaw’s death will be investigated, according to the paper, which names a “complication of AstraZeneca Covid-19 viral immunisation” as a factor.
Shaw, who worked for BBC Radio Newcastle, was not known to suffer from any health issues.
“Lisa got significant headaches a week after having her AstraZeneca immunisation and went gravely ill a few days after,” her family said in a statement.
“She was treated for blood clots and bleeding in her brain by the RVI’s [Royal Victoria Infirmary] critical care team.”
“She tragically died on Friday afternoon, surrounded by her family. We are heartbroken, and a Lisa-shaped void in our lives can never be replaced. We shall always love and miss her.
“Seeing how much she was loved by everyone whose lives she touched has been a big consolation, and we ask for privacy at this time to allow us to grieve as a family.”
Shaw was a “great broadcaster” who was “liked by our listeners,” according to the BBC.
“We’ve lost someone wonderful who meant a lot to a lot of people,” the statement stated.
For most people, the advantages of vaccines outweigh the risks, according to the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA).
“We are heartbroken to learn about Lisa Shaw’s death and our prayers are with her family,” an MHRA representative stated in a statement.
“Reports with a fatal outcome are extensively evaluated by the MHRA, just like any other serious suspected adverse event, including an examination of post-mortem details if available.”
“We’re still doing a thorough investigation into allegations of blood clots and thrombocytopenia.”
Blood clots associated with the Oxford AstraZeneca COVID-19 vaccination are relatively uncommon.
After roughly 35 million doses of the vaccine were delivered, there were 332 recorded illnesses and 58 recorded deaths in the United Kingdom.
The Therapeutic Goods Administration (TGA) said that nine cases of blood clots and low blood platelets had been reported in Australia in the last week in relation with the AstraZeneca vaccination.
Six cases have been confirmed as being linked to the vaccine, with three more cases being considered likely.
In Australia, the vaccine is advised for those over the age of 50, with blood clots being extremely rare.
A blood clot caused by contracting coronavirus is eight times more likely than one caused by the immunisation.
Every day, about 50 Australians get blood clots.
The AstraZeneca vaccine is safe for those with a history of various blood clotting diseases, according to new guidance released by Australia’s primary vaccine safety agency earlier this week.